Literature DB >> 25347945

Transplantation: molecular phenotyping of T-cell-mediated rejection.

Anita S Chong1, David L Perkins2.   

Abstract

A new study has reported a molecular signature of T-cell-mediated rejection in human kidney transplant biopsy samples that is enriched for effector T cells, interferon-γ and macrophages. Inhibitors of T-cell activation, such as CTLA4 and PDL1, were also prominent, raising the possibility that these immunological constrains could be harnessed by therapies for treating rejection.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25347945      PMCID： PMC4425203          DOI： 10.1038/nrneph.2014.197

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

2.  Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies.

Authors:  J Reeve; J Sellarés; M Mengel; B Sis; A Skene; L Hidalgo; D G de Freitas; K S Famulski; P F Halloran
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

3.  Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).

Authors:  P F Halloran; A B Pereira; J Chang; A Matas; M Picton; D De Freitas; J Bromberg; D Serón; J Sellarés; G Einecke; J Reeve
Journal:  Am J Transplant       Date:  2013-10-03       Impact factor: 8.086

Review 4.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

5.  Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

Authors:  Lorraine C Racusen; Robert B Colvin; Kim Solez; Michael J Mihatsch; Philip F Halloran; Patricia M Campbell; Michael J Cecka; Jean-Pierre Cosyns; Anthony J Demetris; Michael C Fishbein; Agnes Fogo; Peter Furness; Ian W Gibson; Denis Glotz; Pekka Hayry; Lawrence Hunsickern; Michael Kashgarian; Ronald Kerman; Alex J Magil; Robert Montgomery; Kunio Morozumi; Volker Nickeleit; Parmjeet Randhawa; Heinz Regele; Daniel Seron; Surya Seshan; Stale Sund; Kiril Trpkov
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

Review 6.  CD4(+) T-cell subsets in transplantation.

Authors:  Zhongmin Liu; Huimin Fan; Shuiping Jiang
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

7.  Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands.

Authors:  J M Venner; K S Famulski; D Badr; L G Hidalgo; J Chang; P F Halloran
Journal:  Am J Transplant       Date:  2014-09-12       Impact factor: 8.086

8.  Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.

Authors:  Vladimir M Liarski; Natalya Kaverina; Anthony Chang; Daniel Brandt; Denisse Yanez; Lauren Talasnik; Gianluca Carlesso; Ronald Herbst; Tammy O Utset; Christine Labno; Yahui Peng; Yulei Jiang; Maryellen L Giger; Marcus R Clark
Journal:  Sci Transl Med       Date:  2014-04-02       Impact factor: 17.956

9.  Antibody-mediated vascular rejection of kidney allografts: a population-based study.

Authors:  Carmen Lefaucheur; Alexandre Loupy; Dewi Vernerey; Jean-Paul Duong-Van-Huyen; Caroline Suberbielle; Dany Anglicheau; Jérôme Vérine; Thibaut Beuscart; Dominique Nochy; Patrick Bruneval; Dominique Charron; Michel Delahousse; Jean-Philippe Empana; Gary S Hill; Denis Glotz; Christophe Legendre; Xavier Jouven
Journal:  Lancet       Date:  2012-11-23       Impact factor: 79.321

10.  SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors.

Authors:  Jaime De Calisto; Ninghai Wang; Guoxing Wang; Burcu Yigit; Pablo Engel; Cox Terhorst
Journal:  Front Immunol       Date:  2014-04-23       Impact factor: 7.561
  10 in total
  3 in total

1.  The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.

Authors:  Hussein Fayyad-Kazan; Wissam H Faour; Bassam Badran; Laurence Lagneaux; Mehdi Najar
Journal:  Inflamm Res       Date:  2016-03-08       Impact factor: 4.575

2.  Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model.

Authors:  Jun Zhu; Takenori Inomata; Masahiro Nakamura; Keiichi Fujimoto; Yasutsugu Akasaki; Kenta Fujio; Ai Yanagawa; Koichiro Uchida; Jaemyoung Sung; Naoko Negishi; Ken Nagino; Yuichi Okumura; Maria Miura; Hurramhon Shokirova; Mizu Kuwahara; Kunihiko Hirosawa; Akie Midorikawa-Inomata; Atsuko Eguchi; Tianxiang Huang; Hideo Yagita; Sonoko Habu; Ko Okumura; Akira Murakami
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.379

3.  Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles.

Authors:  Paul Ostrom Kadota; Zahraa Hajjiri; Patricia W Finn; David L Perkins
Journal:  Front Immunol       Date:  2015-11-06       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.